RARS1 and endometrial carcinoma: Subsequent studies have mainly focused on the relationship between RARs and estrogen or have aimed to determine the mechanism whereby RARs affect endometrial proliferative disorders, such as endometriosis, endometrial hyperplasia, or endometrial carcinoma (18, 19).